<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Biotech CEOs Discuss the Virtues of Going Virtual</title>
	<atom:link href="http://www.xconomy.com/san-diego/2009/03/26/biotech-ceos-discuss-the-virtues-of-going-virtual/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.xconomy.com/san-diego/2009/03/26/biotech-ceos-discuss-the-virtues-of-going-virtual/</link>
	<description>Business + Technology in the Exponential Economy</description>
	<lastBuildDate>Sun, 22 Nov 2009 23:12:44 -0600</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.6</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: Stephen Porter</title>
		<link>http://www.xconomy.com/san-diego/2009/03/26/biotech-ceos-discuss-the-virtues-of-going-virtual/comment-page-1/#comment-51936</link>
		<dc:creator>Stephen Porter</dc:creator>
		<pubDate>Thu, 26 Mar 2009 21:23:26 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=17745#comment-51936</guid>
		<description>I speak with a great deal of experience in this area having espoused and lived in this world for over 15 yrs.  &quot;Virtual drug development&quot; was originally a model put forward by Steven Burrill in 1991 during the last nuclear winter for biotech funding. Is was then and is now a means to stay alive. 

And has been adopted with great  enthusiasm by the Chinese in their start up models.  It will flourish better there than the west due to the culturally engrained natural networking mindset “Guangxi” in China. 

</description>
		<content:encoded><![CDATA[<p>I speak with a great deal of experience in this area having espoused and lived in this world for over 15 yrs.  &#8220;Virtual drug development&#8221; was originally a model put forward by Steven Burrill in 1991 during the last nuclear winter for biotech funding. Is was then and is now a means to stay alive. </p>
<p>And has been adopted with great  enthusiasm by the Chinese in their start up models.  It will flourish better there than the west due to the culturally engrained natural networking mindset “Guangxi” in China.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Virtual Companies Present Alternative Business Model for Start-Ups &#171; Connecticut Technology &#38; Intellectual Property</title>
		<link>http://www.xconomy.com/san-diego/2009/03/26/biotech-ceos-discuss-the-virtues-of-going-virtual/comment-page-1/#comment-51892</link>
		<dc:creator>Virtual Companies Present Alternative Business Model for Start-Ups &#171; Connecticut Technology &#38; Intellectual Property</dc:creator>
		<pubDate>Thu, 26 Mar 2009 16:08:15 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=17745#comment-51892</guid>
		<description>[...] Virtual Companies Present Alternative Business Model for&#160;Start-Ups  26 03 2009   Bruce V. Bigelow, of xconomy.com-San Diego, writes about a CEO panel discussion held at Biocom (a CA life sciences trade association) regarding the advantages and disadvantages of start-ups using a &#8220;virtual company&#8221; business model (See Biotech CEOs Discuss the Virtues of Going Virtual, March 26, 2009). [...]</description>
		<content:encoded><![CDATA[<p>[...] Virtual Companies Present Alternative Business Model for&nbsp;Start-Ups  26 03 2009   Bruce V. Bigelow, of xconomy.com-San Diego, writes about a CEO panel discussion held at Biocom (a CA life sciences trade association) regarding the advantages and disadvantages of start-ups using a &#8220;virtual company&#8221; business model (See Biotech CEOs Discuss the Virtues of Going Virtual, March 26, 2009). [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
